Posted on May 31, 2011 by Debra A. McCurdy

IRS Extends to June 10 the Deadline for Submitting Error Reports on Branded Prescription Drug Sales

This post was originally written for the Life Sciences Legal Update blog by Ruth N. Holzman, Angelo Ciavarella, Joseph W. Metro and Vicky G. Gormanly.

On Friday, May 27, 2011, the Internal Revenue Service ("IRS") issued Notice 2011-46 (the "New Notice"), which extended to June 10, 2011 the deadline to submit error reports in accordance with the dispute resolution process established with respect to the preliminary fee calculation of the 2011 fee imposed on certain manufacturers and importers of branded prescription drugs.

To read the full blog post, please click here.

Tags: , , ,
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.healthindustrywashingtonwatch.com/admin/trackback/250000
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.